Skip to main content

Table 2 Clinical characteristics

From: The evaluation of a remote support program on quality of life and evolution of disease in COPD patients with frequent exacerbations

  

Overall

Treatment non-adherence based on Morisky-Green baseline score

High-Risk

Low-Risk

p-value

N = 114

27 (23.7)

87 (76.3)

 

Time of evolution of COPD (years)

 Mean (S.D.)

 

8.8 (6.8)

7.7 (6.2)

9.2 (7.0)

0.314U

 Missing

 

1

0

1

 

Number of moderate exacerbations in the last 12 months

 Mean (S.D.)

 

1.6 (1.1)

1.5 (0.8)

1.6 (1.2)

0.967U

 Missing

 

0

0

0

 

Number of severe exacerbations in the last 12 months

 Mean (S.D.)

 

1.2 (1.6)

0.7 (1.0)

1.4 (1.8)

0.049U

 Missing

 

0

0

0

 

Total number of exacerbations in the last 12 months

 Mean (S.D.)

 

2.8 (1.4)

2.2 (0.5)

3.0 (1.5)

0.003U

 2–3 exacerbations

n(%)

97 (85.1)

26 (96.3)

71 (81.6)

0.069F

 4 or more exacerbations

n(%)

17 (14.9)

1 (3.7)

16 (18.4)

 

 Missing

 

0

0

0

 

Comorbidities

 Cardiac comorbidities

n(%)

41 (36.0)

8 (29.6)

33 (37.9)

0.432C

 Coronary heart disease (CHD)

n(%)

22 (19.3)

4 (14.8)

18 (20.7)

0.499C

 Peripheral vascular disease

n(%)

13 (11.4)

2 (7.4)

11 (12.6)

0.730F

 Missing

n

0

0

0

 
  1. COPD chronic obstructive pulmonary disease, S.D standard deviation
  2. CChi-square test; FFisher’s exact test; UMann-Whitney U test